MoneyWorks4Me

Lupin submits board meeting intimation

24 Jan 2024 Evaluate
Lupin has informed pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Wednesday, February 7, 2024, to consider and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..